Hi Mary, I am sorry that Joe failed the Dasatinib trial, what is his doctor suggesting next?
If there is active CML which is not being controlled, the red blood cell indices will not be normal. MCV is to do with the size of the red blood cells and MCH is the hemoglobin in the red blood cells. A rise in both can indicate anemia. Joe only has a slight elevation of these parameters. See website below: http://www.healthatoz.com/healthatoz/Atoz/ency/red_blood_cell_indices.jsp Do you know why Joe failed Dasatinib? One reason is the development of a mutation called T315I and if Joe had this, then there is another drug trial targeting the T315I mutation. The drug is VX-680 from Merck and is in Phase I trials at MDACC. Best Wishes, Anjana caregiver to Roy --~--~---------~--~----~------------~-------~--~----~ [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to CMLHope@googlegroups.com To unsubscribe from this group, send email to [EMAIL PROTECTED] For more options, visit this group at http://groups.google.com/group/CMLHope -~----------~----~----~----~------~----~------~--~---
